Ombudsman Jesus Crispin Remulla defended the decision to withdraw and review the Pharmally cases filed at the Sandiganbayan, saying the initial pleadings appeared flawed.
He noted that some cases, including one with no alleged government damage, could confuse the court’s jurisdiction.
The reconfiguration follows suspicions over the hurried filing of the P4-billion graft cases before his appointment.
The cases involve the anomalous purchase of medical equipment from Pharmally during the COVID-19 pandemic, despite the company having a small start-up capital.
A Senate probe later revealed that the government-purchased equipment was substandard, prompting scrutiny of the contracts.
Source: PhilNews24 | November 23, 2025
Latest from Politics
The Alliance of Concerned Teachers (ACT) criticized Senator Ronald “Bato” dela Rosa for his prolonged Senate
Senator Francis “Kiko” Pangilinan urged that farmers and consumers must feel the impact of the Department
Malacañang on Friday assured that due process will be observed following the Philippine Army’s relief of
Senate President Vicente Sotto III said the Senate is prepared to defend the constitutionality of the
The Sandiganbayan has dismissed the graft case against former Agriculture Secretary Proceso Alcala over the alleged
